TIA1
Basic information
Region (hg38): 2:70209444-70248660
Links
Phenotypes
GenCC
Source:
- distal myopathy, Welander type (Supportive), mode of inheritance: AD
- amyotrophic lateral sclerosis 26 with or without frontotemporal dementia (Limited), mode of inheritance: Unknown
- distal myopathy, Welander type (Strong), mode of inheritance: AD
- amyotrophic lateral sclerosis 26 with or without frontotemporal dementia (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia; Welander distal myopathy | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 23348830; 28817800; 29216908 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Welander distal myopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TIA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 40 | 48 | ||||
missense | 93 | 97 | ||||
nonsense | 2 | |||||
start loss | 2 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 9 | 14 | 2 | 25 | ||
non coding | 52 | 26 | 84 | |||
Total | 1 | 0 | 114 | 95 | 32 |
Highest pathogenic variant AF is 0.0000197
Variants in TIA1
This is a list of pathogenic ClinVar variants found in the TIA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-70212723-T-G | Welander distal myopathy | Uncertain significance (May 10, 2022) | ||
2-70212723-TG-T | Welander distal myopathy | Uncertain significance (Sep 04, 2016) | ||
2-70212730-C-T | Welander distal myopathy | Pathogenic (Jan 29, 2024) | ||
2-70212734-C-A | Welander distal myopathy | Likely benign (Aug 31, 2022) | ||
2-70212739-C-T | Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia • Welander distal myopathy | Uncertain significance (Jan 22, 2024) | ||
2-70212756-G-A | Uncertain significance (Jul 01, 2024) | |||
2-70212758-C-T | Welander distal myopathy | Benign/Likely benign (Jan 28, 2024) | ||
2-70212762-T-C | Welander distal myopathy | Uncertain significance (Jul 05, 2022) | ||
2-70212763-T-C | Welander distal myopathy | Uncertain significance (Oct 13, 2023) | ||
2-70212772-T-C | Welander distal myopathy | Uncertain significance (Apr 28, 2023) | ||
2-70212779-A-G | Welander distal myopathy | Benign (Nov 27, 2023) | ||
2-70212779-A-AT | Welander distal myopathy | Uncertain significance (Jul 25, 2022) | ||
2-70212784-G-A | Welander distal myopathy | Uncertain significance (Sep 13, 2019) | ||
2-70212794-C-T | not specified • Welander distal myopathy | Benign/Likely benign (Jan 26, 2024) | ||
2-70212795-G-A | AMYOTROPHIC LATERAL SCLEROSIS 26 WITH FRONTOTEMPORAL DEMENTIA • Welander distal myopathy | Conflicting classifications of pathogenicity (Dec 06, 2023) | ||
2-70212798-T-G | Welander distal myopathy | Uncertain significance (Nov 30, 2022) | ||
2-70212802-C-T | Welander distal myopathy | Conflicting classifications of pathogenicity (Jul 01, 2024) | ||
2-70212808-A-C | Welander distal myopathy | Uncertain significance (Jul 15, 2022) | ||
2-70212810-T-C | Welander distal myopathy • not specified • TIA1-related disorder • Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia | Conflicting classifications of pathogenicity (Jul 01, 2024) | ||
2-70212821-C-A | Welander distal myopathy | Uncertain significance (Sep 15, 2021) | ||
2-70212840-G-A | Uncertain significance (Jul 07, 2021) | |||
2-70212842-C-G | Welander distal myopathy | Uncertain significance (Jul 25, 2022) | ||
2-70212851-G-T | Welander distal myopathy | Likely benign (Nov 14, 2020) | ||
2-70212852-G-A | Welander distal myopathy | Likely benign (Dec 18, 2023) | ||
2-70212853-A-G | Welander distal myopathy | Likely benign (Aug 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TIA1 | protein_coding | protein_coding | ENST00000433529 | 13 | 39217 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.275 | 0.725 | 125737 | 0 | 10 | 125747 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.07 | 129 | 214 | 0.602 | 0.0000108 | 2537 |
Missense in Polyphen | 20 | 50.431 | 0.39658 | 608 | ||
Synonymous | -0.141 | 70 | 68.5 | 1.02 | 0.00000347 | 694 |
Loss of Function | 3.87 | 7 | 29.8 | 0.235 | 0.00000161 | 306 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000932 | 0.0000462 |
European (Non-Finnish) | 0.0000704 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in alternative pre-RNA splicing and regulation of mRNA translation by binding to AU-rich elements (AREs) located in mRNA 3' untranslated regions (3' UTRs). Possesses nucleolytic activity against cytotoxic lymphocyte target cells. May be involved in apoptosis.;
- Disease
- DISEASE: Welander distal myopathy (WDM) [MIM:604454]: An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement. {ECO:0000269|PubMed:23348830, ECO:0000269|PubMed:23401021}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- FGFR2 alternative splicing;Signaling by FGFR2;Signal Transduction;Signaling by FGFR;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.263
Intolerance Scores
- loftool
- 0.354
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.21
Haploinsufficiency Scores
- pHI
- 0.908
- hipred
- Y
- hipred_score
- 0.627
- ghis
- 0.585
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tia1
- Phenotype
- immune system phenotype; skeleton phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;
Gene ontology
- Biological process
- apoptotic process;fibroblast growth factor receptor signaling pathway;negative regulation of translation;negative regulation of cytokine biosynthetic process;regulation of mRNA splicing, via spliceosome;protein localization to cytoplasmic stress granule;positive regulation of epithelial cell apoptotic process
- Cellular component
- nucleoplasm;cytoplasm;cytosol;cytoplasmic stress granule;nuclear stress granule
- Molecular function
- RNA binding;protein binding;poly(A) binding;AU-rich element binding